Inhaled antibiotics are pharmaceutical drugs administered through inhalation to treat respiratory infections. They are delivered directly to the site of infection in the lungs, enabling higher drug concentrations at the target site with lower systemic drug levels and reduced side effects.
The global Inhaled Antibiotics Market is estimated to be valued at US$ 1,403.3 Mn in 2023 and is expected to exhibit a CAGR of 6.7% ... Read more
